Two meals with different carbohydrate, fat and protein contents render equivalent postprandial plasma levels of calprotectin, cortisol, triglycerides and zonulin

References

• Andréasson K, Scheja A, Saxne T, Ohlsson B, Hesselstrand R. 2011. Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med. 270:50–57.
   PubMed Web of Science ®Google Scholar
• Asmar M, Simonsen L, Madsbad S, Stallknecht B, Holst JJ, Bülow J. 2010. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes. 59:2160–2163.
   PubMed Web of Science ®Google Scholar
• Berne C, Fagius J, Pollare T, Hjemdahl P. 1992. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873–879.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Gabrielsen TO, Dale I, Müller F, Steinbakk M, Fagerhol MK. 1995. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol. 371A:201–206.
   PubMedGoogle Scholar
• Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Fernández-Real JM, Salvador J, Frühbeck G. 2011. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 17:1157–1167.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E. 2002. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 106:1211–1218.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J. 2004. Postprandial glucose regulation and diabetic complications. Arch Intern Med. 164:2090–2095.
   PubMed Web of Science ®Google Scholar
• Cholidou KG, Kostakis ID, Manali ED, Perrea D, Margeli A, Vougas K, Markozannes E, et al. 2013. Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea. Cytokine. 61:917–923.
   PubMed Web of Science ®Google Scholar
• Clifton PM, Condo D, Keogh JB. 2014. Long term weight maintenance after advice to consume low carbohydrate, higher protein diets-a systematic review and meta analysis. Nutr Metab Cardiovasc Dis. 24:224–235.
   PubMed Web of Science ®Google Scholar
• Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, De-Fronzo RA. 1994. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 37:1025–1035.
   PubMed Web of Science ®Google Scholar
• Ebenbichler CF, Kirchmair R, Egger C, Patsch JR. 1995. Postprandial state and atherosclerosis. Curr Opin Lipidol. 6:286–290.
   PubMed Web of Science ®Google Scholar
• Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 86:557–566.
   PubMed Web of Science ®Google Scholar
• Eue I, Pietz B, Storck J, Klempt M, Sorg C. 2000. Transendothelial migration of 27E10+ Human monocytes. Int Immunol. 12:1593–1604.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2011. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 91:151–175.
   PubMed Web of Science ®Google Scholar
• Fasano A. 2012. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Ann N Y Acad Sci. 1258:25–33.
   PubMed Web of Science ®Google Scholar
• Fleissig Y, Reichenberg E, Redlich M, Zaks B, Deutsch O, Aframian DJ, Palmon A. 2010. Comparative proteomic analysis of human oral fluids according to gender and age. Oral Dis. 16:831–838.
   PubMed Web of Science ®Google Scholar
• Grieb P, Kłapcińska B, Smol E, Pilis T, Pilis W, Sadowska-Krepa E, Sobczak A, Bartoszewicz Z, Nauman J, Stańczak K, Langfort J. 2008. Long-term consumption of a carbohydrate-restricted diet does not induce deleterious metabolic effects. Nutr Res. 28:825–833.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Ødegård S, Syversen SW, Landewé R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK. 2010. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 69:150–154.
   PubMed Web of Science ®Google Scholar
• Hang I, Heilmann RM, Grützner N, Suchodolski JS, Steiner JM, Atroshi F, Sankari S, Kettunen A, de Vos WM, Zentek J, Spillman T. 2013. Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs. BMC Vet Res. 9:201.
   PubMed Web of Science ®Google Scholar
• Hu T, Bazzano LA. 2014. The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies. Nutr Metab Cardiovasc Dis. 24:337–343.
   PubMed Web of Science ®Google Scholar
• Jakulj F, Zernicke K, Bacon SL, van Wielingen LE, Key BL, West SG, Campbell TS. 2007. A high-fat meal increases cardiovascular reactivity to psychological stress in healthy young adults. J Nutr. 137:935–939.
   PubMed Web of Science ®Google Scholar
• Johansson I, Nilsson LM, Stegmayr B, Boman K, Hallmans G, Winkvist A. 2012. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J. 11:40.
   PubMed Web of Science ®Google Scholar
• Kjeldsen-Kragh J, Mellbye OJ, Haugen M, Mollnes TE, Hammer HB, Sioud M, Førre O. 1995. Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet. Scand J Rheumatol. 24:85–93.
   PubMed Web of Science ®Google Scholar
• Noakes TD. 2013. Low-carbohydrate and high-fat intake can manage obesity and associated conditions: occasional survey. S Afr Med J. 103:826–830.
   PubMed Web of Science ®Google Scholar
• Nordic Nutrition Recommendations. 2012. [Internet]. Available from: http://www.norden.org/en/theme/nordic-nutrition-recommendation/nordic-nutrition-recommendations-2012
   Google Scholar
• Ohlsson B, Höglund P, Roth B, Darwiche G. 2016. Modification of a traditional breakfast leads to increased satiety along with attenuated plasma increments of glucose, C-peptide, insulin, and glucose-dependent insulinotropic polypeptide in humans. Nutr Res. 36:359–368.
   PubMed Web of Science ®Google Scholar
• O'Keefe JH, Gheewala NM, O'keefe JO. 2008. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 51:249–255.
   PubMed Web of Science ®Google Scholar
• Ortega FJ, Sabater M, Moreno-Navarrete JM, Pueyo N, Botas P, Delgado E, Ricart W, Frühbeck G, Fernández-Real JM. 2012. Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. Eur J Endocrinol. 167:569–578.
   PubMed Web of Science ®Google Scholar
• Pedersen L, Nybo M, Poulsen MK, Henriksen JE, Dahl J, Rasmussen LM. 2014. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord. 14:196.
   PubMed Web of Science ®Google Scholar
• Solano M, Goldberg R. 2006. Management of dyslipidemia in diabetes. Cardiol Rev. 14:125–135.
   PubMedGoogle Scholar
• Stimson RH, Mohd-Shukri NA, Bolton JL, Andrew R, Reynolds RM, Walker BR. 2014. The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol production. J Clin Endocrinol Metab. 99:160–168.
   PubMed Web of Science ®Google Scholar
• Stefanutti C, Labbadia G, Athyros VG. 2014. Hypertriglyceridaemia, postprandial lipaemia and non-HDL cholesterol. Curr Pharm Des. 20:6238–6248.
   PubMed Web of Science ®Google Scholar
• Souto A, Salgado E, Maneiro JR, Mera A, Carmona L, Gómez-Reino JJ. 2015. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol. 67:117–127.
   PubMed Web of Science ®Google Scholar
• Stofkova A. 2010. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul. 44:25–36.
   PubMedGoogle Scholar
• Tovar J, Nilsson A, Johansson M, Björck I. 2014. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women. Br J Nutr. 111:706–714.
   PubMed Web of Science ®Google Scholar
• Vitaglione P, Mennella I, Ferracane R, Rivellese AA, Giacco R, Ercolini D, Gibbons SM, La Storia A, Gilbert JA, Jonnalagadda S, et al. 2014. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr. 101:251–261.
   PubMed Web of Science ®Google Scholar
• Wautier JL, Boulanger E, Wautier MP. 2006. Postprandial hyperglycemia alters inflammatory and hemostatic parameters. Diabetes Metab. 32:2S34–2S36.
   Google Scholar
• Zak-Golab A, Kocelak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. 2013. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013:674106.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y. 2014. Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract. 106:312–318.
   PubMed Web of Science ®Google Scholar